About the EULAR COVID-19 Database
The EULAR - COVID-19 Database is a European paediatric and adult database (in collaboration with the Pediatric Rheumatology European Society (PReS)) to monitor and report on outcomes of “Coronavirus Disease 2019” (COVID-19) occurring in patients with rheumatic and musculoskeletal diseases (RMDs). There is an urgent need to understand outcomes of patients who acquire “severe acute respiratory syndrome coronavirus 2” (SARS-CoV‐2) infection and are receiving steroids, synthetic or biologic disease-modifying anti-rheumatic drugs (DMARDs) and non-steroidal anti-inflammatory drugs (NSAIDs). This will help guide rheumatologists and other clinicians such as specialist nurses in advising and caring for their patients.
We are grateful to our international colleagues who have established the COVID-19 Global Rheumatology Alliance1 and helped us establish this database. Anonymised data will be shared with this international registry, based in the United States.
We encourage rheumatology clinicians from across Europe and other EULAR countries to report ALL cases of COVID-19 in their rheumatology patients, regardless of severity (including asymptomatic patients detected through public health screening). Understanding less severe cases or even mild cases will help us understand further those who develop the most severe form.
We hope you will actively contribute to this voluntary reporting system. Through broad scale participation and collaboration, we will be able to answer these very pressing questions for our rheumatology patients and their caregivers.
9 April 2021
EULAR COVID-19 Database
The EULAR - COVID-19 Database is a European paediatric and adult database (in collaboration with the Pediatric Rheumatology European Society (PReS)) to monitor and report on outcomes of “Coronavirus Disease 2019” (COVID-19) occurring in patients with rheumatic and musculoskeletal diseases (RMDs).
To learn more about the Database and report a case of COVID-19 to the EULAR COVID-19 Database
First paper using the combined EULAR & Global Registry Data
Characteristics associated with hospitalization for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Open call for projects using the combined EULAR & Global Registry Data
Submit a proposal to carry out a project using data from both the EULAR COVID-19 Database and the COVID-19 Global Rheumatology Alliance registry.
The call for applications is now closed.
If you have any questions about the database please send an e-mail to email@example.com .
Please note that this email address is for technological clarifications about the database and NOT for patient data and queries.
Back to database